FI972484L - Karsinooman hoito - Google Patents

Karsinooman hoito Download PDF

Info

Publication number: FI972484L
Authority: FI; Finland
Prior art keywords: carcinoma treatment; carcinoma; treatment
Prior art date: 1994-12-13

Application number

FI972484A

Other languages

English (en)

Swedish (sv)

Other versions

FI118918B (fi

FI972484A0 (fi

Inventor

Lawrence Sterling Young

Original Assignee

Univ Birmingham

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-13

Filing date

1997-06-12

Publication date

1997-06-12

1997-06-12 Application filed by Univ Birmingham filed Critical Univ Birmingham

1997-06-12 Publication of FI972484A0 publication Critical patent/FI972484A0/fi

1997-06-12 Publication of FI972484L publication Critical patent/FI972484L/fi

2008-05-15 Application granted granted Critical

2008-05-15 Publication of FI118918B publication Critical patent/FI118918B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

FI972484A 1994-12-13 1997-06-12 CD40-reseptorin sitovan aineen käyttö valmistettaessa lääkettä FI118918B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9425060		1994-12-13
GBGB9425060.2A GB9425060D0 (en)	1994-12-13	1994-12-13	Carcinoma treatment
PCT/GB1995/002807 WO1996018413A1 (en)	1994-12-13	1995-12-01	Carcinoma treatment
GB9502807		1995-12-01

Publications (3)

Publication Number	Publication Date
FI972484A0 FI972484A0 (fi)	1997-06-12
FI972484L true FI972484L (fi)	1997-06-12
FI118918B FI118918B (fi)	2008-05-15

Family

ID=10765814

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI972484A FI118918B (fi)	1994-12-13	1997-06-12	CD40-reseptorin sitovan aineen käyttö valmistettaessa lääkettä

Country Status (12)

Country	Link
EP (1)	EP0806963B1 (fi)
JP (1)	JP4076230B2 (fi)
AT (1)	ATE203676T1 (fi)
AU (1)	AU691996B2 (fi)
CA (1)	CA2207779C (fi)
DE (1)	DE69522012T2 (fi)
FI (1)	FI118918B (fi)
GB (1)	GB9425060D0 (fi)
MX (1)	MX9704372A (fi)
NO (1)	NO318587B1 (fi)
NZ (1)	NZ296161A (fi)
WO (1)	WO1996018413A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0751781T3 (da) *	1993-12-23	2004-08-09	Immunex Corp	Anvendelse af monoklonale antistoffer eller oplöselige oligomere ligander til fremstillingen af et medikament til forebyggelse eller behandling af neoplastiske sygdomme
US7070771B1 (en) *	1996-12-09	2006-07-04	Regents Of The University Of California	Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP1946775A3 (en) *	1998-08-11	2008-08-06	Biogen Idec Inc.	Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
US6946129B1 (en)	1999-06-08	2005-09-20	Seattle Genetics, Inc.	Recombinant anti-CD40 antibody and uses thereof
US8557244B1 (en)	1999-08-11	2013-10-15	Biogen Idec Inc.	Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
US7138379B2 (en) *	2000-07-26	2006-11-21	Schering Aktiengesellschaft	Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
GB0025132D0 (en) *	2000-10-13	2000-11-29	Medical Res Council	Method
AR039067A1 (es) *	2001-11-09	2005-02-09	Pfizer Prod Inc	Anticuerpos para cd40
US7786282B2 (en)	2001-12-06	2010-08-31	The Regents Of The University Of California	Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en)	2002-05-23	2009-02-24	The Regents Of The University Of California	Nucleic acids encoding chimeric CD154 polypeptides
US8277810B2 (en)	2003-11-04	2012-10-02	Novartis Vaccines & Diagnostics, Inc.	Antagonist anti-CD40 antibodies
WO2005044305A2 (en) *	2003-11-04	2005-05-19	Chiron Corporation	Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
US20050136055A1 (en)	2003-12-22	2005-06-23	Pfizer Inc	CD40 antibody formulation and methods
EP1885399B1 (en)	2005-05-26	2010-10-20	Seattle Genetics, Inc.	Humanized anti-cd40 antibodies and their methods of use
US8926979B2 (en)	2005-11-01	2015-01-06	Novartis Ag	Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies
WO2007067032A1 (en)	2005-12-09	2007-06-14	Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam	Means and methods for influencing the stability of cells
ES2444465T5 (es)	2005-12-09	2023-11-30	Academisch Medisch Centrum Bij De Univ Van Amsterdam	Medios y procedimientos para influenciar la estabilidad de las células productoras de anticuerpos
NZ571757A (en)	2006-04-21	2012-01-12	Novartis Ag	Antagonist anti-CD40 antibody pharmaceutical compositions comprising arginine-HCl and a citrate or citric acid buffer
CA2704499C (en)	2007-11-07	2020-03-10	Genentech, Inc.	Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
CN102459639A (zh)	2009-04-18	2012-05-16	健泰科生物技术公司	用于评估b细胞淋巴瘤对抗cd40抗体治疗的响应性的方法
WO2011008093A1 (en)	2009-07-15	2011-01-20	Aimm Therapeutics B.V.	Means and methods for producing high affinity antibodies
AR083847A1 (es)	2010-11-15	2013-03-27	Novartis Ag	Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40
NZ611600A (en)	2010-12-02	2015-02-27	Aimm Therapeutics Bv	Means and methods for producing high affinity antibodies
US8778345B2 (en)	2011-04-29	2014-07-15	Apexigen, Inc.	Anti-CD40 antibodies
WO2014070934A1 (en)	2012-10-30	2014-05-08	Apexigen, Inc.	Anti-cd40 antibodies and methods of use
AU2015211480B2 (en)	2014-01-31	2020-05-14	Kling Biotherapeutics B.V.	Means and methods for producing stable antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5540926A (en) *	1992-09-04	1996-07-30	Bristol-Myers Squibb Company	Soluble and its use in B cell stimulation

1994
- 1994-12-13 GB GBGB9425060.2A patent/GB9425060D0/en active Pending
1995
- 1995-12-01 WO PCT/GB1995/002807 patent/WO1996018413A1/en not_active Ceased
- 1995-12-01 AU AU39884/95A patent/AU691996B2/en not_active Ceased
- 1995-12-01 DE DE69522012T patent/DE69522012T2/de not_active Expired - Lifetime
- 1995-12-01 JP JP51844696A patent/JP4076230B2/ja not_active Expired - Fee Related
- 1995-12-01 NZ NZ296161A patent/NZ296161A/en not_active IP Right Cessation
- 1995-12-01 AT AT95938518T patent/ATE203676T1/de active
- 1995-12-01 EP EP95938518A patent/EP0806963B1/en not_active Expired - Lifetime
- 1995-12-01 MX MX9704372A patent/MX9704372A/es not_active IP Right Cessation
- 1995-12-01 CA CA002207779A patent/CA2207779C/en not_active Expired - Fee Related
1997
- 1997-06-12 FI FI972484A patent/FI118918B/fi active IP Right Grant
- 1997-06-13 NO NO19972732A patent/NO318587B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO1996018413A1 (en)	1996-06-20
NO972732D0 (no)	1997-06-13
JP4076230B2 (ja)	2008-04-16
EP0806963A1 (en)	1997-11-19
CA2207779A1 (en)	1996-06-20
ATE203676T1 (de)	2001-08-15
FI118918B (fi)	2008-05-15
CA2207779C (en)	2009-10-06
FI972484A0 (fi)	1997-06-12
GB9425060D0 (en)	1995-02-08
NO972732L (no)	1997-06-13
AU3988495A (en)	1996-07-03
MX9704372A (es)	1998-02-28
DE69522012T2 (de)	2002-04-25
AU691996B2 (en)	1998-05-28
NZ296161A (en)	2001-10-26
EP0806963B1 (en)	2001-08-01
DE69522012D1 (de)	2001-09-06
NO318587B1 (no)	2005-04-11
JPH10510526A (ja)	1998-10-13

Publication	Publication Date	Title
FI972484L (fi)	1997-06-12	Karsinooman hoito
NO983266D0 (no)	1998-07-15	Distribuert Behandling
DE69517659D1 (de)	2000-08-03	Verbinder
DE69718990D1 (de)	2003-03-20	Behandlungsgerät
DE69524193D1 (de)	2002-01-10	Massagegerät
TR199501053A2 (tr)	1996-06-21	Tedavide yararli spiro-azabisiklik bilesikler.
DE69513916D1 (de)	2000-01-20	Oberflächenbehandlungszusammensetzung
DE69523489D1 (de)	2001-12-06	Verbinder
DE69521660D1 (de)	2001-08-16	Verbinder
IS4789A (is)	1998-06-30	Meðferðarefnasambönd
NO983263D0 (no)	1998-07-15	Distribuert behandling
DE69514764D1 (de)	2000-03-02	Massagegerät
DE69526175D1 (de)	2002-05-08	Behandlungsgerät
DE69528458D1 (de)	2002-11-07	Bandbehandlungsvorrichtung
FI964532L (fi)	1996-11-12	Ristiluminenssin vähentäminen
DE69516439D1 (de)	2000-05-31	Behandlungsgerät
ATA218894A (de)	1996-12-15	Physikotherapeutische behandlungsvorrichtung
KR960013388U (ko)	1996-05-17	지압기
MD281F1 (ro)	1995-09-30	Masajor magnetodinamic
KR950026706U (ko)	1995-10-16	치료용 발열기
KR950024525U (ko)	1995-09-13	침관
KR960020164U (ko)	1996-07-18	지압구
KR950026717U (ko)	1995-10-16	지압구
KR960009986U (ko)	1996-04-12	마사지기
KR960003039U (ko)	1996-01-22	개선된 파마로이

Legal Events

Date	Code	Title	Description
2008-05-15	FG	Patent granted	Ref document number: 118918 Country of ref document: FI

Date

Code

Title

Description

2008-05-15

Patent granted

Ref document number: 118918

Country of ref document: FI